SUNPHARMA Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > sunpharma

Technical Analysis

Technical Strength: 4.7 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 45.9. According to RSI analysis, sunpharma is technically weak. 1.0 SUNPHARMA RSI Chart
MACD (?) MACD: -16.3 and Signal Line: -22.5. According to MACD analysis, sunpharma is marginally strong. 7.0 SUNPHARMA MACD Chart
Simple Moving Average (?) According to simple moving average analysis, sunpharma is facing resistance at 594 and support level is at 522.915. 6.0 SUNPHARMA Simple Moving Average Chart
Exponential Moving Average (?) Price just got above it's 20-day exponential moving average which is a positive signal. According to exponential moving average analysis, sunpharma is facing resistance at 581 and support level is at 542.4891. 7.0 SUNPHARMA Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.887. According to bollinger bands, sunpharma is technically strong. 7.0 SUNPHARMA Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is below all levels. Resistance levels are 571.8004 and 596.25. Support level is 492.65. 2.5 SUNPHARMA Fibonacci Retracement Chart
Average True Range (?) ATR: 15.6 NA SUNPHARMA Average True Range Chart
Average Directional Index (?) ADX is 35.3 which means SUNPHARMA is in a trend. NA SUNPHARMA Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
June 23, 2017
Open Price 538.0
High Price 545.5
Low Price 537.0
Close Price 543.8
Absolute Change 5.1
Percentage Change 0.947%
Weekly Change 2.77%
Monthly Change -4.2%
Yearly Change -26.8%
52-week high 854.95
52-week low 492.65
Corporate Actions
ExDate Purpose
September 08, 2016 AGM/DIV-RE 1/- PER SHARE
July 14, 2016 BUY BACK
October 21, 2015 AGM/DIV-RS 3 PER SHARE
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.591
Confidence in Beta1.8%
Market Capital Rs. 130876.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. 8.9
TTM Price-to-Earnings (P/E) Ratio 61.1
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 23 June 2017: Deliverable Quantity:2.21e+06 NA SUNPHARMA Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 23 June 2017: Daily Volatility:0.4318 NA SUNPHARMA Annualized Daily Volatility (Spot Price) Chart

Futures & Options Analysis

Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
PCR (?) 23 June 2017: PCR_OI:0.434 PCR:0.534 NA SUNPHARMA PCR Chart
Premium (?) 23 June 2017 Premium: 0.3 Futures OI:29178100.0 NA SUNPHARMA Premium Chart
Option_MAX_OI (?) 23 June 2017: Price:543.8 Put with maximum OI:520.0 Call with maximum OI:560.0 NA SUNPHARMA Option_MAX_OI Chart

Futures - NSE

Expiry Date Close Price Open Interest Number of Trades No of Contracts Underlying Closing Price
June 29, 2017 544.1 29178100.0 8914.0 11779.0 543.8
July 27, 2017 546.5 7189600.0 2662.0 4123.0 543.8
August 31, 2017 549.35 96800.0 31.0 36.0 543.8

Announcements

June 22, 2017 SCourt Convened Meeting UpdatesSun Pharmaceutical Industries Limited has informed the Exchange that Voting Results of National Company Law Tribunal ( NCLT") convened meeting of the equity shareholders of the Company held on June 20, 2017 along with Scrutinizers' Report.
June 21, 2017 SCourt Convened Meeting UpdatesSun Pharmaceutical Industries Limited has informed the Exchange regarding Proceedings of National Company Law Tribunal ( NCLT") convened separate meetings of the equity shareholders and unsecured creditors of Sun Pharmaceutical Industries Limited ( the Company ) held on June 20, 2017
See all Announcements

Board Meetings

Date Meeting Date Purpose
January 27, 2017 February 14, 2017 TResultsTo consider and take on record the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2016.
October 25, 2016 November 10, 2016 TResults/OthersTo transact, interalia, the following business:
See all Board Meetings

SUNPHARMA is part of...

Index Weightage
NIFTY NA
CNXPHARMA NA

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 530.2 Rs. 533.6 Rs. 538.7 Rs. 542.1 Rs. 547.2 Rs. 550.6 Rs. 555.7